Singhal Kritika, Taywade Manish, Patro Binod K, Pal Debkumar, Behera Priyamadhaba, Mishra Abhisek K
Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
J Educ Health Promot. 2024 Jul 5;13:180. doi: 10.4103/jehp.jehp_1249_23. eCollection 2024.
We developed the "rule of seven" intervention because different targets related to diabetes control can somehow be calculated by multiplication of seven. This study aimed to evaluate the effectiveness of the "rule of seven" in improving glycemic control in patients diagnosed with diabetes by measuring fasting plasma glucose and 2 hours postprandial plasma glucose.
This two-arm randomized controlled trial will compare the effectiveness of the "rule of seven" intervention in achieving glycemic control in diabetes mellitus patients. The patients in the control arm will receive routine patient counseling related to diabetes mellitus. Patients registered with the noncommunicable disease (NCD) clinics of All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Community Health Center (CHC) Tangi, and CHC Mendhasala will be recruited consecutively during clinic hours after fulfilling eligibility criteria and obtaining written informed consent. The sample size was estimated as 426 in each group. The ethical permission was obtained from the Institutional Ethics Committee (IEC) and prospectively registered in the Clinical Trial Registry of India (CTRI/2023/07/055522).
After the intervention, we will find out the change in knowledge regarding parameters related to glycemic status; discover the change in biochemical parameters after 1, 3, and 6 months; and conclude whether those changes are statistically significant or not.
我们开发了“七法则”干预措施,因为与糖尿病控制相关的不同目标在某种程度上可以通过乘以七来计算。本研究旨在通过测量空腹血糖和餐后2小时血糖,评估“七法则”对改善糖尿病患者血糖控制的有效性。
这项双臂随机对照试验将比较“七法则”干预措施在实现糖尿病患者血糖控制方面的有效性。对照组的患者将接受与糖尿病相关的常规患者咨询。在满足入选标准并获得书面知情同意后,将在门诊时间连续招募在布巴内斯瓦尔全印度医学科学研究所(AIIMS)、坦吉社区卫生中心(CHC)和门德哈萨拉社区卫生中心的非传染性疾病(NCD)诊所登记的患者。每组样本量估计为426例。已获得机构伦理委员会(IEC)的伦理许可,并在印度临床试验注册中心(CTRI/2023/07/055522)进行了前瞻性注册。
干预后,我们将了解血糖状态相关参数的知识变化;发现1、3和6个月后生化参数的变化;并得出这些变化是否具有统计学意义的结论。